Enterococcus casseliflavus Infection: A Review of Clinical Features and Treatment

Figures & data

Table 1 Summary of the Treatment Courses for All Reported Bacteremia Cases

No	Citation	Age (Years)	Gender	Diagnosis	Multiple Organisms Detected	Definitive Treatment for Enterococcus casseliflavus Bacteremia	Outcome
1	9	63	Male	Bacteremia/Infective endocarditis	Yes	Daptomycin for 6 weeks	Survived
2	10	86	Female	Bacteremia/Infective endocarditis	No	Ampicillin and gentamicin for 6 weeks	Survived
3	11	56	Male	Bacteremia/Spontaneous bacterial peritonitis	No	Meropenem (Duration unknown)	Survived
4	12	74	Male	Bacteremia/Cholangitis	Yes	Daptomycin for 2 weeks	Survived
5	13	72	Male	Bacteremia	No	Ampicillin for 6 weeks	Survived
6	14	24 weeks	Female	Bacteremia	No	Ampicillin and netilmicin for 12 days	Survived
7	15	39	Male	Bacteremia	Yes	Ertapenem for 6 weeks, followed by amoxicillin-clavulanate (duration unknown)	Survived
8	16	75	Male	Bacteremia	No	Ampicillin for 2 weeks	Survived
9	17	87	Male	Bacteremia	Yes	Ampicillin for about 2 weeks, followed by linezolid for 2 weeks	Survived
10	18	80	Female	Bacteremia	Yes	Ampicillin-sulbactam for 10 days	Survived
11	19	19	Female	Bacteremia	No	Ampicillin and teicoplanin for 2 weeks	Survived